A hospital lipid-lowering protocol improves 2-year clinical outcomes in patients with acute coronary syndrome
AsiaIntervention 2024;10:169-176
Clinical safety and performance of the world’s thinnest-strut Evermine50 everolimus-eluting stent: a 24-month follow-up of the Evermine 50 EES – 1 study
AsiaIntervention 2024;10:195-202
Impact of acute coronary syndrome on early in-stent neoatherosclerosis as shown by optical coherence tomography
AsiaIntervention 2024;10:203-211
Impact of real-time optical coherence tomography and angiographic coregistration on the percutaneous coronary intervention strategy
AsiaIntervention 2023;9:124-132
Reduced-dose prasugrel monotherapy without aspirin after PCI with the SYNERGY stent in East Asian patients presenting with chronic coronary syndromes or non-ST-elevation acute coronary syndromes: rationale and design of the ASET Japan pilot study
AsiaIntervention 2023;9:39-48
Diagnostic accuracy of reperfusion criteria following fibrinolysis for ST-elevation myocardial infarction
AsiaIntervention 2023;9:49-51
Percutaneous coronary intervention of anomalous right coronary arteries arising from the left sinus of Valsalva: a single-centre experience from Northern India
AsiaIntervention 2023;9:32-38
Coronary physiology in the catheterisation laboratory: an A to Z practical guide
AsiaIntervention 2022;8:86-109
Percutaneous coronary intervention in patients aged 80 years old and above: a systematic review and meta-analysis
AsiaIntervention 2022;8:123-131
Aggressive lipid-lowering therapy after percutaneous coronary intervention – for whom and how?
AsiaIntervention 2022;8:24-31